<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35490234</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>03</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2377</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Apr</Month><Day>30</Day></PubDate></JournalIssue><Title>BMC neurology</Title><ISOAbbreviation>BMC Neurol</ISOAbbreviation></Journal><ArticleTitle>Palliative sedation in amyotrophic lateral sclerosis: results of a nationwide survey among neurologists and palliative care practitioners in Germany.</ArticleTitle><Pagination><StartPage>161</StartPage><MedlinePgn>161</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">161</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12883-022-02681-7</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Palliative sedation has become widely accepted as a method to alleviate refractory symptoms in terminally ill patients. Controversies regarding this topic especially concern the use of palliative sedation for psychological symptoms, the use in patients who are not imminently dying and the simultaneous withdrawal of life-sustaining measures. Amyotrophic lateral sclerosis (ALS) is characterized by symptoms including muscle weakness, dysphagia, dysarthria, muscle spasms and progressive respiratory insufficiency. Due to these characteristic symptoms, palliative sedation might be considered to be necessary to alleviate refractory suffering in ALS patients. However, palliative sedation in ALS is only rarely discussed in current medical literature and guidelines.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A questionnaire survey was conducted among neurologists and palliative care practitioners in Germany. The participants were asked to evaluate the use of palliative sedation in different situations.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Two hundred and ninety-six completed questionnaires were analyzed. The results suggest high levels of support for the use of palliative sedation in ALS patients. 42% of the participants stated that they had already used palliative sedation in the treatment of ALS patients. Acceptance of palliative sedation was higher in case of physical symptoms than in case of psychological symptoms. Refusal of artificial nutrition did not lead to a lower acceptance of palliative sedation. Doctors with specialist training in palliative care had already used palliative sedation in ALS patients more often and they were more likely to accept palliative sedation in different situations than the participants without a background in palliative care.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our survey showed that palliative sedation in ALS is widely accepted by the attending doctors. In case of psychological symptoms, palliative sedation is looked at with more concern than in case of physical symptoms. The refusal of artificial nutrition does not result in a decreased acceptance of palliative sedation. Doctors with specialist training in palliative care are more likely to approve of palliative sedation in ALS.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Salzmann</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Hematology, Oncology and Palliative Medicine, Medical Center Bad Hersfeld, Bad Hersfeld, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alt-Epping</LastName><ForeName>Bernd</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Palliative Medicine, University Hospital Heidelberg, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simon</LastName><ForeName>Alfred</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Academy of Ethics in Medicine, University Medical Center Goettingen, Goettingen, Germany. Asimon1@gwdg.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Neurol</MedlineTA><NlmUniqueID>100968555</NlmUniqueID><ISSNLinking>1471-2377</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>BMC Neurol. 2022 May 23;22(1):188</RefSource><PMID Version="1">35606720</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005858" MajorTopicYN="N" Type="Geographic">Germany</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072141" MajorTopicYN="N">Neurologists</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010166" MajorTopicYN="Y">Palliative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis (ALS)</Keyword><Keyword MajorTopicYN="N">Palliative care</Keyword><Keyword MajorTopicYN="N">Palliative sedation</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>1</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>4</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>30</Day><Hour>23</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35490234</ArticleId><ArticleId IdType="pmc">PMC9055769</ArticleId><ArticleId IdType="doi">10.1186/s12883-022-02681-7</ArticleId><ArticleId IdType="pii">10.1186/s12883-022-02681-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cherny NI, Radbruch L. The Board of the European Association for Palliative Care. European Association for Palliative Care (EAPC) recommended framework for the use of sedation in palliative care. Palliat Med. 2009;23:581&#x2013;93. doi: 10.1177/0269216309107024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0269216309107024</ArticleId><ArticleId IdType="pubmed">19858355</ArticleId></ArticleIdList></Reference><Reference><Citation>Neitzke G, Oehmichen F, Schliep HJ, W&#xf6;rdehoff D. Sedierung am Lebensende. Empfehlungen der AG Ethik am Lebensende in der Akademie f&#xfc;r Ethik in der Medizin (AEM) Ethik in der Medizin. 2010;22:139&#x2013;47. doi: 10.1007/s00481-010-0054-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00481-010-0054-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Intentional sedation as a means to ease suffering: a systematically constructed terminology for sedation in palliative care. https://www.liebertpub.com/doi/epdf/10.1089/jpm.2021.0428. Accessed 13 Mar 2022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9081045</ArticleId><ArticleId IdType="pubmed">35073180</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaspers B, Nauck F, Lindena G, Elsner F, Ostgathe C, Radbruch L. Palliative sedation in Germany: how much do we know? A prospective survey. J Palliat Med. 2012;15:672&#x2013;680. doi: 10.1089/jpm.2011.0395.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jpm.2011.0395</ArticleId><ArticleId IdType="pubmed">22656056</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller-Busch HC. &#x201c;Terminale Sedierung&#x201d; Ausweg im Einzelfall, Mittelweg oder schiefe Ebene? Ethik in der Medizin. 2004;16:369&#x2013;377. doi: 10.1007/s00481-004-0326-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00481-004-0326-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon A, Kar M, Hinz J, Beck D. Attitudes towards terminal sedation: an empirical survey among experts in the field of medical ethics. BMC Palliat Care. 2007;6:4. doi: 10.1186/1472-684X-6-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1472-684X-6-4</ArticleId><ArticleId IdType="pmc">PMC1855046</ArticleId><ArticleId IdType="pubmed">17437628</ArticleId></ArticleIdList></Reference><Reference><Citation>Oechsle K, Radbruch L, Wolf C, Ostgathe C. SOP &#x2013; Palliative Sedierung. Onkologe. 2017;23:469&#x2013;475. doi: 10.1007/s00761-017-0240-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00761-017-0240-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon A. Kommentar II. Ethik in der Medizin. 2008;20:138&#x2013;9. doi: 10.1007/s00481-008-0559-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00481-008-0559-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Schildmann E, Schildmann J. Palliative sedation therapy: a systematic literature review and critical appraisal of available guidance on indication and decision making. J Palliat Med. 2014;17:601&#x2013;611. doi: 10.1089/jpm.2013.0511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jpm.2013.0511</ArticleId><ArticleId IdType="pubmed">24809466</ArticleId></ArticleIdList></Reference><Reference><Citation>Cellarius V. Terminal sedation and the &#x201c;imminence condition.&#x201d; J Med Ethics. 2008;34:69&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">18234940</ArticleId></ArticleIdList></Reference><Reference><Citation>Neitzke G, Frewer A. Sedierung als Sterbehilfe?: Zur medizinethischen Kultur am Lebensende. Ethik in der Medizin. 2004;16:323&#x2013;333. doi: 10.1007/s00481-004-0329-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00481-004-0329-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Orentlicher D. The supreme court and terminal sedation: rejecting assisted suicide embracing euthanasia. Hastings Constit Law Q. 1997;24:22.</Citation><ArticleIdList><ArticleId IdType="pubmed">11657288</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon A. Entscheidungen am Lebensende. In: Erbguth F, Jox RJ, editors. Angewandte Ethik in der Neuromedizin. Berlin: Springer-Verlag; 2017.</Citation></Reference><Reference><Citation>Ludolph AC, Anneser J. Die Amyotrophe Lateralsklerose und andere Motoneuronenerkrankungen. In: Brandt T, Diener HC, Gerloff C, editors. Therapie und Verlauf neurologischer Erkrankungen. Stuttgart: Kohlhammer; 2012.</Citation></Reference><Reference><Citation>Deutsche Gesellschaft f&#xfc;r Neurologie, editor. Amyotrophe Lateralsklerose (Motoneuronerkrankung). 2015.</Citation></Reference><Reference><Citation>The EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis. Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, et al. EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS) &#x2013; revised report of an EFNS task force. Eur J Neurol. 2012;19:360&#x2013;75. doi: 10.1111/j.1468-1331.2011.03501.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2011.03501.x</ArticleId><ArticleId IdType="pubmed">21914052</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludolph AC, Meyer T. Edaravone: eine neue Substanz f&#xfc;r die Behandlung der ALS. DGN - Deutsche Gesellschaft f&#xfc;r Neurologie. 2017. https://www.dgn.org/neuronews/54-neuronews-2017/3436-edaravone-eine-neue-substanz-fuer-die-behandlung-der-als. Accessed 23 Apr 2020.</Citation></Reference><Reference><Citation>Arantzamendi M, Belar A, Payne S, Rijpstra M, Preston N, Menten J, et al. Clinical aspects of palliative sedation in prospective studies a systematic review. J Pain Symptom Manage. 2021;61:831&#x2013;844.e10. doi: 10.1016/j.jpainsymman.2020.09.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpainsymman.2020.09.022</ArticleId><ArticleId IdType="pubmed">32961218</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliver DJ. Palliative care in motor neurone disease: where are we now? Palliat Care. 2019;12:117822421881391.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6348498</ArticleId><ArticleId IdType="pubmed">30718958</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon A, Kar M, Hinz J, Beck D. Attitudes towards terminal sedation: an empirical survey among experts in the field of medical ethics. BMC Palliat Care. 2007;6:4. doi: 10.1186/1472-684X-6-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1472-684X-6-4</ArticleId><ArticleId IdType="pmc">PMC1855046</ArticleId><ArticleId IdType="pubmed">17437628</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell JA, Williams MA, Drogan O. Sedation for the imminently dying: survey results from the AAN Ethics Section. Neurology. 2010;74:1303&#x2013;1309. doi: 10.1212/WNL.0b013e3181d9edcb.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181d9edcb</ArticleId><ArticleId IdType="pubmed">20237307</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipuma SH. Continuous sedation until death as physician-assisted suicide/euthanasia: a conceptual analysis. J Med Philo. 2013;38:jht005.</Citation><ArticleIdList><ArticleId IdType="pubmed">23449365</ArticleId></ArticleIdList></Reference><Reference><Citation>Hallenbeck JL. Terminal sedation: ethical implications in different situations. J Palliat Med. 2000;3:313&#x2013;320. doi: 10.1089/jpm.2000.3.313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jpm.2000.3.313</ArticleId><ArticleId IdType="pubmed">15859672</ArticleId></ArticleIdList></Reference><Reference><Citation>van Oorschot B, Lipp V, Tietze A, Nickel N, Simon A. Einstellungen zur Sterbehilfe und zu Patientenverf&#xfc;gungen: Ergebnisse einer Befragung von 727 &#xc4;rzten. Dtsch med Wochenschr. 2005;130:261&#x2013;265. doi: 10.1055/s-2005-837410.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-2005-837410</ArticleId><ArticleId IdType="pubmed">15692898</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber M, Stiehl M, Reiter J, Rittner C. Ethische Entscheidungen am Ende des Lebens. Sorgsames Abw&#xe4;gen der jeweiligen Situation. Ergebnisse einer &#xc4;rztebefragung in Rheinland-Pfalz. Deutsches &#xc4;rzteblatt. 2001;48:5.</Citation></Reference><Reference><Citation>Association for Palliative Medicine of Great Britain and Ireland, editor. Withdrawal of assisted ventilation at the request of a patient with motor neurone disease. 2015.</Citation></Reference><Reference><Citation>Beauchamp TL, Childress JF. Principles of Biomedical Ethics. New York: Oxford University Press; 2001.</Citation></Reference><Reference><Citation>Nationaler Ethikrat. Selbstbestimmung und F&#xfc;rsorge am Lebensende. Stellungnahme. 2006.</Citation></Reference><Reference><Citation>Thurn T, Borasio GD, Chi&#xf2; A, Galvin M, McDermott CJ, Mora G, Sermeus W, Winkler AS, Anneser J. Physicians&#x2019; attitudes toward end-of-life decisions in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20:74&#x2013;81. doi: 10.1080/21678421.2018.1536154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2018.1536154</ArticleId><ArticleId IdType="pubmed">30789031</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer T, Dullinger JS, M&#xfc;nch C, Keil J-P, Hempel E, Rosseau S, et al. Elektive Termination der Beatmungstherapie bei der amyotrophen Lateralsklerose. Nervenarzt. 2008;79:684&#x2013;690. doi: 10.1007/s00115-008-2439-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00115-008-2439-9</ArticleId><ArticleId IdType="pubmed">18330539</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>